目的：探讨可溶性肿瘤坏死因子受体在消化道恶性肿瘤患者中的临床意义。
Objective to probe into the clinical significance of serum soluble tumor necrosis factor receptors in patients with malignant carcinoma of digestive system.
目的了解血清可溶性肿瘤坏死因子受体(STNFR)1,2与胰岛素抵抗(IR)的关系。
Objective to study the relationship between soluble tumor necrosis factor receptor (STNFR) 1, 2 and insulin resistance (IR).
可溶性肿瘤坏死因子型受体在斑秃发病中的作用。
Role of Soluble Tumor Necrosis Factor Receptor Type I in Alopecia Areata.
肿瘤坏死因子受体抑制剂，人可溶性，重组。
Tumor Necrosis Factor Receptor Inhibitor, Human Soluble, recombinant.
检测了72例肾移植患者血中可溶性白细胞介素2受体（SIL-2R）、肿瘤坏死因子（TNF）及白细胞介素6（IL-6）的水平。
The levels of soluble interlukin- 2 receptor (SIL-2R), tumor necrosis factor (TNF) , and interlukin- 6 (IL-6) were measured in 72 renal allograft recipients.
依那西普是一个重组可溶性肿瘤坏死因子- α受体融合蛋白，它可结合肿瘤坏死因子- α 。
Etanercept is a recombinant soluble TNF-alpha receptor fusion protein that binds to TNF-alpha.
依那西普是一个重组可溶性肿瘤坏死因子- α受体融合蛋白，它可结合肿瘤坏死因子- α 。
Etanercept is a recombinant soluble TNF-alpha receptor fusion protein that binds to TNF-alpha.
应用推荐